Explore peer-reviewed research articles, clinical trials, and molecular pathways in inflammatory diseases
Discover how dendrimer-like mesoporous silica nanoparticles (DMSNs) are transforming IBD treatment by delivering interleukin-22 (IL-22) with unprecedented precision.